CN1732953A - 一种治疗高血压的分散片 - Google Patents
一种治疗高血压的分散片 Download PDFInfo
- Publication number
- CN1732953A CN1732953A CN 200510097977 CN200510097977A CN1732953A CN 1732953 A CN1732953 A CN 1732953A CN 200510097977 CN200510097977 CN 200510097977 CN 200510097977 A CN200510097977 A CN 200510097977A CN 1732953 A CN1732953 A CN 1732953A
- Authority
- CN
- China
- Prior art keywords
- irbesartan
- hydrochlorothiazide
- disintegrating agent
- preferred
- dispersible tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
样品 | 溶出度占标示量的% | |||||
5分钟 | 15分钟 | 30分钟 | ||||
厄贝沙坦 | 氢*** | 厄贝沙坦 | 氢*** | 厄贝沙坦 | 氢*** | |
实施例5 | 79.3% | 87.1% | 102.0% | 99.8% | 98.4% | 99.6% |
实施例6 | 81.4% | 88.1% | 99.5% | 100.3% | 97.2% | 99.1% |
市售复方厄贝沙坦普通片 | 49.4% | 52.7% | 87.3% | 92.7% | 95.1% | 101.8% |
项目 | 市售片剂 | 实施例5的处方 | ||
厄贝沙坦 | 氢*** | 厄贝沙坦 | 氢*** | |
主药含量 | 150mg | 12.5mg | 150mg | 12.5mg |
体外崩解时间 | 17.5分钟 | 1分钟 | ||
5分钟体外溶出度 | 49.4% | 52.7% | 79.3% | 87.1% |
30分钟体外溶出度 | 95.1% | 101.8% | 98.4% | 99.6% |
体内生物利用度试验的达峰时间 | 2.15±0.76hr | 1.95±0.87hr | 1.57±0.62hr | 1.42±0.56hr |
相对生物利用度 | -- | -- | 112.1±12.9% | 105.8±9.70% |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510097977 CN1732953B (zh) | 2005-09-02 | 2005-09-02 | 一种治疗高血压的分散片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510097977 CN1732953B (zh) | 2005-09-02 | 2005-09-02 | 一种治疗高血压的分散片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1732953A true CN1732953A (zh) | 2006-02-15 |
CN1732953B CN1732953B (zh) | 2010-05-05 |
Family
ID=36075709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510097977 Active CN1732953B (zh) | 2005-09-02 | 2005-09-02 | 一种治疗高血压的分散片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1732953B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100417384C (zh) * | 2005-12-28 | 2008-09-10 | 严洁 | 厄贝沙坦氢***分散片 |
WO2011141783A3 (en) * | 2010-04-13 | 2012-04-26 | Micro Labs Limited | Pharmaceutical composition comprising irbesartan |
CN102580097A (zh) * | 2012-03-16 | 2012-07-18 | 江苏先声药物研究有限公司 | 一种含阿齐沙坦的药物组合物 |
CN102793704A (zh) * | 2011-05-25 | 2012-11-28 | 苏州洪瑞医药科技有限公司 | 一种厄贝沙坦和环戊噻嗪药物组合物及其制备方法 |
CN106706785A (zh) * | 2016-12-23 | 2017-05-24 | 东药集团沈阳施德药业有限公司 | 一种采用高效液相色谱检测厄贝沙坦氢***片中有关物质的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1199641C (zh) * | 2002-10-24 | 2005-05-04 | 王登之 | 一种用于治疗高血压的复方厄贝沙坦胶囊 |
-
2005
- 2005-09-02 CN CN 200510097977 patent/CN1732953B/zh active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100417384C (zh) * | 2005-12-28 | 2008-09-10 | 严洁 | 厄贝沙坦氢***分散片 |
WO2011141783A3 (en) * | 2010-04-13 | 2012-04-26 | Micro Labs Limited | Pharmaceutical composition comprising irbesartan |
CN102793704A (zh) * | 2011-05-25 | 2012-11-28 | 苏州洪瑞医药科技有限公司 | 一种厄贝沙坦和环戊噻嗪药物组合物及其制备方法 |
CN102580097A (zh) * | 2012-03-16 | 2012-07-18 | 江苏先声药物研究有限公司 | 一种含阿齐沙坦的药物组合物 |
CN106706785A (zh) * | 2016-12-23 | 2017-05-24 | 东药集团沈阳施德药业有限公司 | 一种采用高效液相色谱检测厄贝沙坦氢***片中有关物质的方法 |
CN106706785B (zh) * | 2016-12-23 | 2019-02-26 | 东药集团沈阳施德药业有限公司 | 一种采用高效液相色谱检测厄贝沙坦氢***片中有关物质的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1732953B (zh) | 2010-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1732952A (zh) | 一种治疗高血压的复方分散片 | |
CN1135103C (zh) | 经舌下或含服给药的控释药物 | |
CN1298317C (zh) | 坦洛新片剂 | |
CN101052381A (zh) | 包含替米沙坦和氨氯地平的双层片剂 | |
JP2011098964A (ja) | 被覆錠剤製剤 | |
CN1787811A (zh) | 口腔崩解片 | |
CN1461212A (zh) | 水凝胶驱动的药物剂型 | |
CN101073563A (zh) | 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片 | |
CN1732953A (zh) | 一种治疗高血压的分散片 | |
CN109875972B (zh) | 一种奥美沙坦酯氨氯地平药物组合物 | |
CN105078974A (zh) | 一种阿利沙坦酯固体分散体及药物组合物 | |
CN1527700A (zh) | 制备苯妥英钠剂型的压缩方法 | |
CN1943564A (zh) | 吲达帕胺缓释片及其制备方法 | |
CN1883480A (zh) | 一种含卢帕他定的药物组合物 | |
CN1805741A (zh) | 利用湿法造粒制备的稳定的阿托伐他汀组合物 | |
CN1887277A (zh) | 含有降血脂成分的分散片及其制备方法 | |
CN1684681A (zh) | 比西发定制剂 | |
CN1642532A (zh) | 曲马多缓释制剂 | |
CN1608621A (zh) | 双环醇微粉化及口服控释制剂 | |
CN1903194A (zh) | 辛伐他汀的缓、控释制剂及其制备方法 | |
CN101066267A (zh) | 一种含有阿立哌唑微晶的固体口服药物组合物 | |
CN1771945A (zh) | 托拉塞米分散片及其制备方法和应用 | |
CN100336511C (zh) | 口服罗红霉素控释制剂 | |
CN1303990C (zh) | 阿魏酸钠口腔崩解片及其制备工艺 | |
CN1433311A (zh) | 制备生物利用度改善的麦角生物碱持续释放药物组合物的方法及其组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090306 Address after: 1-4,1-5 unit, United States industrial village, 100 Nanhai Avenue, Hainan, Haikou Province, China: 570216 Applicant after: Bikai Pharmaceutical Industry Co., Ltd., Hainan Address before: No. 688, Hai Lu, Haimen Economic Development Zone, Jiangsu: 226100 Applicant before: Yao Junhua |
|
ASS | Succession or assignment of patent right |
Owner name: HAINAN BIKAI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YAO JUNHUA Effective date: 20090306 |
|
ASS | Succession or assignment of patent right |
Owner name: YAO JUNHUA Free format text: FORMER OWNER: HAINAN BIKAI PHARMACEUTICAL CO., LTD. Effective date: 20090807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090807 Address after: No. 688, Hai Lu, Haimen Economic Development Zone, Jiangsu: 226100 Applicant after: Yao Junhua Address before: 1-4,1-5 unit, United States industrial village, 100 Nanhai Avenue, Hainan, Haikou Province, China: 570216 Applicant before: Bikai Pharmaceutical Industry Co., Ltd., Hainan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YAO JUNHUA Effective date: 20120307 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120307 Address after: 226100 Jiangsu Province Haimen Economic Development Zone Dinghai Road No. 688 Patentee after: Jiaosu Wangao Pharmaceutical Co., Ltd. Address before: 226100 Jiangsu Province Haimen Economic Development Zone Dinghai Road No. 688 Patentee before: Yao Junhua |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 226100 Jiangsu Province Haimen Economic Development Zone Dinghai Road No. 688 Patentee after: Jiangsu Wangao Pharmaceutical Co., Ltd. Address before: 226100 Jiangsu Province Haimen Economic Development Zone Dinghai Road No. 688 Patentee before: Jiaosu Wangao Pharmaceutical Co., Ltd. |